AN EXPERIENCED pharmaceutical industry leader has been appointed as Director of the Pharmaceutical Manufacturing Technology Centre at University of Limerick.
Damon Warnock, who has a wealth of knowledge and experience having previously worked for global biopharmaceutical company Alkermes and Irish firm Elan, has been appointed to the role at the research centre, which is situated within UL’s Bernal Institute.
Through his work, Damon has gotten an insight into the importance of the Pharmaceutical Manufacturing Technology Centre (PMTC) as his industry work has seen him collaborate with the centre on several projects.
Funded by Enterprise Ireland, in partnership with IDA Ireland, the centre is an applied research and innovation hub focused on using advanced technology and analytics to address contemporary manufacturing issues impacting on efficiency and sustainability for the pharmaceutical sector.
Reacting to his appointment, Damon said he was looking forward to his new role as director to guide PMTC in its next phase of development.
“I am truly excited to be joining the wonderful team at PMTC, becoming part of UL and Enterprise Ireland’s powerful research organisations,” he said.
“Our aim is to build on PMTC’s collaboration successes to-date and expand pharmaceutical industry’s access to, and usage of, effective technology and data analytics solutions within their business processes”.
PMTC is an industry-led hub aimed at supporting Irish companies to grow their businesses, create jobs, and deliver significant wider economic impact while deepening links with the world’s leading pharmaceutical firms, many of which are based in Ireland.
